Sian Garwood 
ExpressionEdits in Cambridge has clinched unspecified riches from global pharmaceutical company Boehringer Ingelheim through a collaboration and licensing agreement.
The programme, with two unique options – the EpiFund and EpiBoost to suit startups, R&D spinouts, and established SMEs – originally had an application deadline of 31st January, 2025 but will now be extended indefinitely.
From start-up founders to seasoned investors, scientists, and policy-makers, every milestone during 2024 reflects the power of human connectivity in shaping a better future.
More government help is needed to fund start-up companies in the computer games industry, the head of a leading gaming firm has told BBC Politics East.
EDR Technology Group, a business focused in delivering energy and communications solutions, has established a new office at The EpiCentre in Haverhill.
This exclusive session will teach you how to showcase your business to attractive investors and introduce you to Demo Directly. You will get to hear success stories from founders who have used the platform, and discover key insights about investor engagement and funding trends.
An experienced chef who once cooked for the late Queen Elizabeth II has been appointed to run The EpiCentre’s, The Hub café.
The biotech sector is pivotal in innovation and scientific advancements and is going from strength-to-strength. But often for start-ups in this space, success comes down to more than just breakthrough science. It’s also about location, collaboration, and the resources to scale innovation effectively.
With over 13,000 founders, investors, and innovators from 90+ countries, Slush was a whirlwind of networking, inspiring talks, and game-changing ideas.
This is the launch of Oxford Innovation Sessions; a series of six talks from industry leaders on the latest trends in AI, Business Development, Marketing and more. We have secured … Read more
Join an inspiring community of innovators and entrepreneurs.
Stay in touch with what’s happening at The EpiCentre. Pop in your details below and confirm you’re happy for us to send you emails, and we’ll keep you up to date with all that’s happening at The EpiCentre.
Disclaimer: The EpiCentre uses the information you provide on this form to get in touch with you and provide updates and for marketing purposes. You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us. We treat all personal information with respect. By subscribing, you agree that we may process your information in accordance with these terms.
Space to experiment, space to research
Space to experiment, space to research
Update – 11 August 2022
Our Innovation Centres remain operational and accessible, and provide a safe environment for our staff and customers. We continue to assess the risk of COVID-19 alongside the latest guidance from government. In the meantime our Innovation Centre remains COVID-19 Secure and fully open for business. Our detailed risk assessment can be found here.
